Wedbush Issues Positive Forecast for DAWN Earnings
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Stock analysts at Wedbush increased their Q2 2025 earnings estimates for Day One Biopharmaceuticals in a research note issued to investors on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of ($0.33) per share for the quarter, up from […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Stock analysts at Wedbush increased their Q2 2025 earnings estimates for Day One Biopharmaceuticals in a research note issued to investors on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of ($0.33) per share for the quarter, up from […]
